Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility

Occupational and Environmental Medicine

Volumn 60, Issue 10, 2003, Pages 722-729

  Alexander, B H ^a   Olsen, G W ^b   Burris, J M ^b   Mandel, J H ^b   Mandel, J S ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b 3M COMPANY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORIDE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANESULFONYL FLUORIDE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER CANCER; CAUSE OF DEATH; CHEMICAL INDUSTRY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; RISK FACTOR; WORK ENVIRONMENT; WORKING TIME;

ADULT; CAUSE OF DEATH; CHEMICAL INDUSTRY; ENVIRONMENTAL MONITORING; EPIDEMIOLOGIC METHODS; FEMALE; FLUOROCARBONS; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCTANOIC ACIDS; URINARY BLADDER NEOPLASMS;

EID: 0141682585     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.60.10.722     Document Type: Article

References (34)

1. M Company. SIDS initial assessment report: perfluorooctane sulphonic acid and its salts: USEPA Public Docket AR-226. Saint Paul: 3M Company, 2000.
2. Seacat AM, Butenhoff JL. Comparative sub-chronic toxicity of perfluorooctane sulphonate (PFOS) and N-ethyl perfluorooctanesulphonamide ethanol (N-EtFOSE) in the rat. Toxicologist 2001;60:348.
3. Seacat AM, Thomford PJ, J HK, et al. Subchronic toxicity studies on perfluorooctanesulphate potassium salt in cynomolgus monkeys. Toxicol Sci 2002;68:249-64.
4. Case MT, York FG, Christian MS. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol 2001;20:101-9.
5. Luebker DJ, Hansen KJ, Bass N, et al. Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 2002;176:175-85.
6. Wallace KB, Luebker DJ, Butenhoff JL, et al. Perfluorooctanesulphonate and 2-(n-ethylperfluorooctanesulphonaminde)-ethyl alcohol are peroxisome proliferators in rats, but not guinea pigs. Toxicologist 2001;60:348.
7. Starkov A, Butenhoff JL, Seacat AM, et al. Structural determinants of mitochondrial dysfunction caused by in vitro exposure to selected perfluorootanyl compounds. Toxicologist 2001;60:1658.
8. Hansen KJ, Clemen LA, Ellefson ME, et al. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 2001;35:766-70.
9. Giesy JP, Kannan K. Global distribution of perfluoroctane sulphonate and related perfluorinated compounds in wildlife. Environ Sci Technol 2001;35:1339-42.
10. Olsen GW, Logan PW, Simpson CA, et al. An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring. Am Indust Hyg Assoc J In press.
11. Olsen GW, Logan PW, Simpson CA, et al. Fluorochemical exposure assessment of Decatur chemical and film plant employees. USEPA Public Docket AR-226. Saint Paul: 3M Company, 1999.
12. Olsen GW, Burris JM, Mandel JH, et al. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med 1999;41:799-806.
13. National Institutes for Occupational Safety and Health. PC LTAS: life table analysis system for use on the PC. Cincinnati: US Department of Health and Human Services, 1998.
14. 14-C. Project 8900310200. Saint Paul, MN: Riker Laboratories Inc., 1979.
15. Seacat AM, Thomford PJ, Butenhoff JL. Terminal observations in Sprague-Dawley rats after lifetime dietary exposure to potassium perfluorooctane sulfonate. Toxicologist 2002;66:185.
16. Thomford PJ, Seacat AM, Butenhoff JL. Terminal observations in Sprague-Dawley rats after liftime dietary exposure to N-ethyl perfluorooctanesulfonamide ethanol. Toxicologist 2002;66:185.
17. Silverman DT, Morrison AS, Devesa SS. Bladder cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996:1156-79.
18. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: Some flame retardants and textile chemicals and exposures in the textile manufacturing industry. Lyon: IARC, 1990.
19. Vineis P, Pirastu R. Aromatic amines and cancer. Cancer Causes Control 1997;8:346-55.
20. Boffetla P, Jourenkova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 1997;8:444-72.
21. Ward EM, Burnett CA, Ruder A, et al. Industries and cancer. Cancer Causes Control 1997;8:356-70.
22. Bonassi S, Merlo F, Pearce N, et al. Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer 1989;44:648-51.
23. Hours M, Dananche B, Fevotte J, et al. Bladder cancer and occupational exposures. Scand J Work Environ Health 1994;20:322-30.
24. Steineck G, Plato N, Norell SE, et al. Urothelial cancer and some industry-related chemicals: an evaluation of the epidemiologic literature. Am J Ind Med 1990;17:371-91.
25. Anton-Culver H, Lee-Feldstein A, Taylor TH. Occupation and bladder cancer risk. Am J Epidemiol 1992;136:89-94.
26. Weiss NS. Cancer in relation to occupational exposure to perchloroethylene. Cancer Causes Control 1995;6:257-66.
27. Porru S, Aulentl V, Donato F, et al. Bladder cancer and occupation: a case-control study in northern Italy. Occup Environ Med 1996;53:6-10.
28. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide (Part One). Lyon: IARC, 1999.
29. Haughom B, Spydevold O. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid, perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim Biophys Acta 1992;1128:65-72.
30. Sibinski LJ. Two-year oral (diet) toxicity/carcinogenicity of fluorochemical FC-143 in rats. Saint Paul: Riker Laboratories, 1987.
31. Biegel LB, Liu RCM, Hurtt ME, et al. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol Appl Pharmacol 1995;134:18-25.
32. Obourn JD, Frame SR, Bell RH, et al. Mechanisms for the pancreaeatic oncogenic effects of peroxisome proliferator Wyeth-14,643. Toxicol Appl Pharmacol 1997:145.
33. Cattley RC, DeLuca J, Elcanbe E, et al. Do peroxisome proliferating compunds pose a hepatocarciongenic hazard to humans. Regul Toxicol Pharmacol 1998;27:47-60.
34. London WT, McGlynn KA. Liver cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996:772-93.